dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii has been researched along with Experimental Mammary Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, K; Gust, R; Schertl, S; Schneider, MR; Schönenberger, H; Spruss, T | 1 |
| Bernhardt, G; Schlemmer, R; Schönenberger, H; Spruss, T | 1 |
2 other study(ies) available for dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II), a new drug not only parenterally but also orally active in the therapy of breast and prostate cancer.
Topics: Administration, Oral; Animals; Antineoplastic Agents; Female; Injections, Subcutaneous; Male; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Models, Biological; Neoplasms, Hormone-Dependent; Organ Size; Organoplatinum Compounds; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Uterus | 1993 |
[meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloroplatinum(II), a compound with a specific activity on hormone-sensitive breast cancers--evidence for a diethylstilbestrol-like mode of action.
Topics: Animals; Antineoplastic Agents, Hormonal; Diethylstilbestrol; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred Strains; Neoplasms, Hormone-Dependent; Organoplatinum Compounds; Ovariectomy; Receptors, Estrogen | 1999 |